| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
9,938 |
8,146 |
$621K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
3,927 |
3,561 |
$305K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
1,142 |
956 |
$99K |
| 87150 |
|
172 |
170 |
$72K |
| 80050 |
General health panel |
1,827 |
1,826 |
$55K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
548 |
548 |
$49K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
2,702 |
2,682 |
$47K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
459 |
447 |
$42K |
| 90472 |
Immunization administration, each additional vaccine (list separately) |
1,232 |
1,231 |
$39K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
1,010 |
970 |
$29K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
689 |
633 |
$28K |
| 96132 |
|
250 |
250 |
$26K |
| 84481 |
|
1,564 |
1,562 |
$23K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
246 |
242 |
$20K |
| 80061 |
Lipid panel |
1,587 |
1,584 |
$18K |
| 93922 |
|
239 |
238 |
$13K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
98 |
98 |
$10K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
101 |
100 |
$9K |
| 84436 |
|
1,455 |
1,453 |
$9K |
| 90688 |
|
659 |
659 |
$8K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
224 |
215 |
$7K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
457 |
439 |
$7K |
| 96138 |
|
249 |
249 |
$6K |
| 87486 |
|
174 |
172 |
$6K |
| 87581 |
|
174 |
172 |
$6K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
174 |
172 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
409 |
370 |
$5K |
| 86328 |
|
116 |
112 |
$5K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
564 |
562 |
$5K |
| 84439 |
|
534 |
534 |
$4K |
| 36415 |
Collection of venous blood by venipuncture |
319 |
312 |
$2K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
267 |
252 |
$2K |
| 81025 |
|
193 |
182 |
$1K |
| J0702 |
Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
85 |
82 |
$801.97 |
| 80053 |
Comprehensive metabolic panel |
82 |
78 |
$713.47 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
31 |
31 |
$646.97 |
| 90715 |
|
38 |
38 |
$560.25 |
| 90474 |
|
25 |
25 |
$458.50 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
20 |
19 |
$395.66 |
| 92567 |
|
25 |
24 |
$299.25 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
43 |
39 |
$298.56 |
| 82670 |
|
12 |
12 |
$261.49 |
| 81002 |
|
71 |
62 |
$214.21 |
| 80305 |
|
13 |
13 |
$145.73 |
| 99490 |
Ccm add 20min |
27 |
27 |
$74.66 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
41 |
40 |
$62.52 |
| 90647 |
|
26 |
26 |
$0.00 |
| 90651 |
|
14 |
14 |
$0.00 |
| 90723 |
|
15 |
15 |
$0.00 |
| 90677 |
|
14 |
14 |
$0.00 |
| 90680 |
|
26 |
26 |
$0.00 |
| 90670 |
|
101 |
101 |
$0.00 |